查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
流感诊断市场：趋势、机会与竞争分析 [2023-2028]
市场调查报告书
商品编码
1342047

流感诊断市场：趋势、机会与竞争分析 [2023-2028]

Influenza Diagnostic Market: Trends, Opportunities and Competitive Analysis [2023-2028]
出版日期: | 出版商: Lucintel | 英文 150 Pages | 商品交期: 3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

流感诊断市场趋势与预测

预计到 2028 年，全球流感诊断市场将达到 15 亿美元，2023 年至 2028 年年复合成长率为 4.1%。该市场的主要促进因素是慢性病的增加、政府监测流感的措施不断加强以及技术先进的流感诊断测试的引入。全球流感诊断市场的未来看起来充满希望，诊断实验室和医院/诊所市场存在商机。

流感诊断市场洞察

  • Lucintel 预测，由于对诊断技术的流感研究数量不断增加以及世界对该疾病早期诊断的认识不断增强，分子诊断检测在预测期内仍将是最大的细分市场。
  • 我们还预测，由于医院数量的增加、人们对流感诊断意识的增强以及对快速诊断检测设备的需求不断增长，医院和诊所仍将是最大的细分市场。
  • 由于人口高龄化加剧、流感患病上升以及主要参与者的存在，北美仍然是预测期内最大的地区。

本报告回答了 11 个关键问题：

  • Q.1. 细分市场中最有前途和高成长的机会是什么？
  • Q.2. 哪些是最有前景和高成长的细分市场？
  • Q.3.您认为哪些地区未来会出现更快的成长？为什么？
  • Q.4. 影响市场动态的主要要素有哪些？市场的主要挑战和商业风险是什么？
  • Q.5. 这个市场的商业风险和竞争威胁是什么？
  • Q.6.这个市场有哪些新趋势？为什么？
  • Q.7.市场客户需求有何改变？
  • Q.8. 该市场有哪些新发展以及哪些公司处于领先地位？
  • Q.9.这个市场的主要企业有哪些？此外，主要企业正在采取什么样的策略配合措施？
  • Q10.该市场的竞争产品有哪些？因材料或产品替代而导致市场占有率下降的威胁有多大？
  • Q11.过去年度发生了哪些併购事件，对产业产生了哪些影响？

目录

第1章执行摘要

第2章全球流感诊断市场：市场动态

  • 简介、背景、分类
  • 供应链
  • 产业促进因素与挑战

第3章2017-2028年市场趋势及预测分析

  • 宏观经济趋势（2017-2022）与预测（2023-2028）
  • 全球流感诊断市场趋势（2017-2022）与预测（2023-2028）
  • 按产品的全球流感诊断市场
    • 检测套组和试剂
    • 乐器
    • 其他的
  • 按测试类型分類的全球流感诊断市场
    • 传统测试
    • 分子诊断分析
    • 其他的
  • 按最终用途产业分類的全球流感诊断市场
    • 诊断实验室
    • 医院和诊所
    • 其他的

第4章2017-2028年分地区市场趋势及预测分析

  • 全球流感诊断市场（按地区）
  • 北美流感诊断市场
  • 欧洲流感诊断市场
  • 亚太流感诊断市场
  • 其他区域流感诊断市场

第5章竞争分析

  • 产品系列分析
  • 营运整合
  • 波特五力分析

第6章成长机会与策略分析

  • 成长机会分析
    • 按产品的全球流感诊断市场成长机会
    • 按测试类型分類的全球流感诊断市场成长机会
    • 按最终用途产业分類的全球流感诊断市场成长机会
    • 全球流感诊断市场区域成长机会
  • 全球流感诊断市场新趋势
  • 战略分析
    • 新产品开发
    • 全球流感诊断市场的产能扩张
    • 全球流感诊断市场的合併、收购与合资企业
    • 认证和许可

第7章主要企业概况

  • 3M
  • Hoffmann-La Roche
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific
  • Hologic
  • Quidel Corporation
  • Abbott Laboratories
  • Sekisui Diagnostics
  • SA Scientific
  • Meridian Bioscience
简介目录

Influenza Diagnostic Market Trends and Forecast

The future of the global influenza diagnostic market looks promising with opportunities in the diagnostic laboratory and hospital & clinic markets. The global influenza diagnostic market is expected to reach an estimated $1.5 billion by 2028 with a CAGR of 4.1% from 2023 to 2028. The major drivers for this market are increasing number of chronic diseases, growing government initiatives to monitor influenza, and introduction of technologically advanced influenza diagnostics tests.

Influenza Diagnostic Market

A more than 150-page report is developed to help in your business decisions.

Influenza Diagnostic Market by Segment

The study includes trends and forecast for the global influenza diagnostic market by product, test type, end use industry, and region, as follows:

Influenza Diagnostic Market by Product [Shipment Analysis by Value from 2017 to 2028]:

  • Test kits and reagents
  • Instruments
  • Others

Influenza Diagnostic Market by Test Type [Shipment Analysis by Value from 2017 to 2028]:

  • Traditional Tests
  • Molecular Diagnostic Assays
  • Others

Influenza Diagnostic Market by End Use Industry [Shipment Analysis by Value from 2017 to 2028]:

  • Diagnostic Laboratories
  • Hospitals & Clinics
  • Others

Influenza Diagnostic Market by Region [Shipment Analysis by Value from 2017 to 2028]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Influenza Diagnostic Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies influenza diagnostic companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the influenza diagnostic companies profiled in this report include:

  • 3M
  • Hoffmann-La Roche
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific
  • Hologic
  • Quidel Corporation
  • Abbott Laboratories
  • Sekisui Diagnostics
  • SA Scientific
  • Meridian Bioscience

Influenza Diagnostic Market Insights

  • Lucintel forecasts that molecular diagnostic assay will remain the largest segment over the forecast period due to increasing number of influenza research for diagnostic technologies along with rising awareness of early diagnosis of disease across the globe.
  • Within this market, hospitals & clinics will remain the largest segment because of rising number of hospitals, growing awareness of influenza diagnostics among people, and increasing demand for rapid diagnostic testing equipment.
  • North America will remain the largest region over the forecast period due to growing aging population, increasing prevalence of influenza, and existence of key players in this region.

Features of the Influenza Diagnostic Market

  • Market Size Estimates: Influenza diagnostic market size estimation in terms of value ($B)
  • Trend and Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
  • Segmentation Analysis: Influenza diagnostic market size by various segments, such as by product, test type, end use industry, and region
  • Regional Analysis: Influenza diagnostic market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
  • Growth Opportunities: Analysis on growth opportunities in different by product, test type, end use industry, and regions for the influenza diagnostic market.
  • Strategic Analysis: This includes M&A, new product development, and competitive landscape for the influenza diagnostic market.
  • Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

  • Q1. What is the influenza diagnostic market size?
  • Answer: The global influenza diagnostic market is expected to reach an estimated $1.5 billion by 2028.
  • Q2. What is the growth forecast for influenza diagnostic market?
  • Answer: The global influenza diagnostic market is expected to grow with a CAGR of 4.1% from 2023 to 2028.
  • Q3. What are the major drivers influencing the growth of the influenza diagnostic market?
  • Answer: The major drivers for this market are increasing number of chronic diseases, growing government initiatives to monitor influenza, and introduction of technologically advanced influenza diagnostics tests.
  • Q4. What are the major segments for influenza diagnostic market?
  • Answer: The future of the global influenza diagnostic market looks promising with opportunities in the diagnostic laboratory and hospital & clinic markets.
  • Q5. Who are the key influenza diagnostic companies?
  • Answer: Some of the key influenza diagnostic companies are as follows:
    • 3M
    • Hoffmann-La Roche
    • Becton, Dickinson and Company
    • Thermo Fisher Scientific
    • Hologic
    • Quidel Corporation
    • Abbott Laboratories
    • Sekisui Diagnostics
    • SA Scientific
    • Meridian Bioscience
  • Q6. Which influenza diagnostic segment will be the largest in future?
  • Answer:Lucintel forecasts that molecular diagnostic assay will remain the largest segment over the forecast period due to increasing number of influenza research for diagnostic technologies along with rising awareness of early diagnosis of disease across the globe.
  • Q7. In influenza diagnostic market, which region is expected to be the largest in next 5 years?
  • Answer: North America will remain the largest region over the forecast period due to growing aging population, increasing prevalence of influenza, and existence of key players in this region.
  • Q8. Do we receive customization in this report?
  • Answer: Yes, Lucintel provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the global influenza diagnostic market by product (test kits and reagents, instruments, and others), test type (traditional tests, molecular diagnostic assays, and others), end use industry (diagnostic laboratories, hospitals & clinics, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q11. What M&A activity has occurred in the last five years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Influenza Diagnostic Market: Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2017 to 2028

  • 3.1. Macroeconomic Trends (2017-2022) and Forecast (2023-2028)
  • 3.2. Global Influenza Diagnostic Market Trends (2017-2022) and Forecast (2023-2028)
  • 3.3: Global Influenza Diagnostic Market by Product
    • 3.3.1 Test Kits and Reagents
    • 3.3.2 Instruments
    • 3.3.3 Others
  • 3.4 Global Influenza Diagnostic Market by Test Type
    • 3.4.1 Traditional Tests
    • 3.4.2 Molecular Diagnostic Assays
    • 3.4.3 Others
  • 3.5 Global Influenza Diagnostic Market by End Use Industry
    • 3.5.1 Diagnostic Laboratories
    • 3.5.2 Hospitals & Clinics
    • 3.5.3 Others

4. Market Trends and Forecast Analysis by Region from 2017 to 2028

  • 4.1: Global Influenza Diagnostic Market by Region
  • 4.2: North American Influenza Diagnostic Market
    • 4.2.1: North American Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
    • 4.2.2: North American Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others
  • 4.3: European Influenza Diagnostic Market
    • 4.3.1: European Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
    • 4.3.2: European Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others
  • 4.4: APAC Influenza Diagnostic Market
    • 4.4.1: APAC Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
    • 4.4.2: APAC Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others
  • 4.5: ROW Influenza Diagnostic Market
    • 4.5.1: ROW Influenza Diagnostic Market by Test Type: Traditional Tests, Molecular Diagnostic Assays, and Others
    • 4.5.2: ROW Influenza Diagnostic Market by End Use Industry: Diagnostic Laboratories, Hospitals & Clinics, and Others

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Influenza Diagnostic Market by Product
    • 6.1.2: Growth Opportunities for the Global Influenza Diagnostic Market by Test Type
    • 6.1.3: Growth Opportunities for the Global Influenza Diagnostic Market by End Use Industry
    • 6.1.4: Growth Opportunities for the Global Influenza Diagnostic Market Region
  • 6.2: Emerging Trends in the Global Influenza Diagnostic Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Influenza Diagnostic Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Influenza Diagnostic Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1 3M
  • 7.2 Hoffmann-La Roche
  • 7.3 Becton, Dickinson and Company
  • 7.4 Thermo Fisher Scientific
  • 7.5 Hologic
  • 7.6 Quidel Corporation
  • 7.7 Abbott Laboratories
  • 7.8 Sekisui Diagnostics
  • 7.9 SA Scientific
  • 7.10 Meridian Bioscience